OpenAI’s IPO Delay Could Be the Biggest Warning Yet for AI Investors

Photo of Rich Duprey
By Rich Duprey Published

Quick Read

  • OpenAI is weighing a delay until 2027 rather than accept a valuation below Sam Altman's $1 trillion target.

  • SpaceX shares now trade below their IPO opening price, cooling Wall Street's appetite for trillion-dollar debuts from OpenAI and Anthropic.

  • Wall Street now rewards AI companies with durable revenue and clear profitability paths over those relying solely on future potential.

  • Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.

OpenAI’s IPO Delay Could Be the Biggest Warning Yet for AI Investors

© Chunumunu / iStock via Getty Images

The AI trade has gone from unstoppable to unpredictable in a matter of weeks. After driving one of the strongest rallies in market history, artificial intelligence stocks have run into a wall of rising valuations, growing capital spending concerns, and a string of volatile IPOs. 

Earlier this week, I suggested the changing market mood might convince Anthropic to postpone its planned public debut. It turns out that possibility wasn’t limited to one company. According to The New York Times, OpenAI is now considering doing that very thing — and that could say more about today’s market than any single earnings report.

The Market Gets Another Reality Check

OpenAI confidentially filed for an IPO earlier this month, with CEO Sam Altman reportedly targeting a valuation of $1 trillion. But according to The New York Times, financial advisers have since urged the company to choose between two paths: wait until 2027 in hopes of supporting that valuation or go public sooner at a lower price. Reuters also reported that CFO Sarah Friar has already told some employees to expect a 2027 launch. Altman reportedly rejected lowering the valuation target.

The shift is significant because OpenAI isn’t just another AI startup. It is the company many investors expected to become the defining IPO of the AI era. Now, the market is changing.

Tech stock turbulence raised the plausible question of whether Anthropic might delay its IPO, and now one of the industry’s biggest names appears to be reaching the same conclusion. That doesn’t necessarily mean AI demand is fading. Instead, it suggests management teams are questioning whether public investors are still willing to pay peak valuations.

Why the Timing Is Important

The timing isn’t hard to understand. Recent technology IPOs have reminded Wall Street that excitement alone doesn’t guarantee lasting gains. SpaceX‘s (NASDAQ:SPCX) record public debut initially produced a surge before its shares pulled back, creating fresh doubts about how much appetite remains for trillion-dollar stories. SpaceX’s stock is trading below its IPO opening price this morning.

If volatility persists, retail investors could become less enthusiastic about OpenAI, Anthropic, or any other company seeking an immediate, outsized valuation.

Company Current IPO Status Anticipated Valuation
OpenAI Considering delaying until 2027 $850 billion to $1 trillion
Anthropic IPO plans increasingly uncertain amid volatility $900 billion to $1 trillion
SpaceX Recently completed IPO $1.97 trillion (current)

Granted, OpenAI still has advantages most startups would envy. Microsoft (NASDAQ:MSFT | MSFT Price Prediction) remains a major strategic partner, while demand for ChatGPT and enterprise AI continues expanding. Yet even those strengths may not overcome a market that has become much more selective about paying premium prices.

Surprisingly, the decision to wait could strengthen OpenAI’s long-term position. If management believes the business deserves a trillion-dollar valuation, delaying may be preferable to pricing the company below its expectations.

What to Watch For Next

For investors, the biggest takeaway extends beyond OpenAI. A delayed IPO would signal that even the leaders of the AI revolution recognize today’s market has become less forgiving. Public investors are demanding stronger financial discipline alongside rapid revenue growth.

That shift also raises the bar for companies throughout the AI ecosystem — from chipmakers to cloud providers to software developers. Businesses with durable revenue, improving cash flow, and clear paths to profitability are likely to command better valuations than companies relying primarily on future potential.

In any case, AI spending isn’t disappearing. The timing of when investors are willing to fund the next generation of AI leaders is what has changed.

Key Takeaway

OpenAI delaying its IPO until 2027 would be less a sign of weakness than an acknowledgment that market conditions have changed. It seemed plausible Anthropic would be the first major AI company to rethink its public debut, but with OpenAI apparently reaching the same conclusion, it may be a fait accompli for its rival. 

Ultimately, smart investors should view that as evidence that valuation once again matters. The AI revolution remains intact, but Wall Street is showing it no longer intends to pay any price for growth.

Photo of Rich Duprey
About the Author Rich Duprey →

After two decades of patrolling the dark corners of suburbia as a police officer, Rich Duprey hung up his badge and gun to begin writing full time about stocks and investing. For the past 20 years he’s been cruising the markets looking for companies to lock up as long-term holdings in a portfolio while writing extensively on the broad sectors of consumer goods, technology, and industrials. Because his experience isn’t from the typical financial analyst track, Rich is able to break down complex topics into understandable and useful action points for the average investor. His writings have appeared on The Motley Fool, InvestorPlace, Yahoo! Finance, and Money Morning. He has been featured in both U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, and USA Today.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

MRNA Vol: 4,582,652
FDS Vol: 227,758
NOW Vol: 8,512,287
INCY Vol: 962,871
WDAY Vol: 1,137,847

Top Losing Stocks

ON Vol: 15,819,820
TER Vol: 1,426,115
WDC Vol: 4,058,221
CTRA Vol: 73,319,495
MPWR Vol: 423,460